Similar articles

• Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.

  Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z. Zhong Y, et al. J Control Release. 2015 May 10;205:144-54. doi: 10.1016/j.jconrel.2015.01.012. Epub 2015 Jan 14. J Control Release. 2015. PMID: 25596560
• Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.

  Liu J, Wei T, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X, Liang XJ. Liu J, et al. Biomaterials. 2016 Jun;91:44-56. doi: 10.1016/j.biomaterials.2016.03.013. Epub 2016 Mar 10. Biomaterials. 2016. PMID: 26994877
• Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.

  Zeng X, Morgenstern R, Nyström AM. Zeng X, et al. Biomaterials. 2014 Jan;35(4):1227-39. doi: 10.1016/j.biomaterials.2013.10.042. Epub 2013 Nov 7. Biomaterials. 2014. PMID: 24210875
• [Hepatic arterial infusion chemotherapy (anthracycline)].

  Yoshikawa M, Ebara M, Saisho H, Ueda S. Yoshikawa M, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:612-6. Nihon Rinsho. 2001. PMID: 11762022 Review. Japanese. No abstract available.
• Reflections on the development of resistance during therapy for advanced breast cancer. Implications of high levels of activity of docetaxel in anthracycline-resistant breast cancer patients.

  Ravdin PM. Ravdin PM. Eur J Cancer. 1997 Aug;33 Suppl 7:S7-10. doi: 10.1016/s0959-8049(97)90002-2. Eur J Cancer. 1997. PMID: 9486096 Review.